About the Authors

Stefan Bentink

Contributed equally to this work with: Stefan Bentink, Benjamin Haibe-Kains

Affiliations Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard School of Public Health, Boston, Massachusetts, United States of America

Benjamin Haibe-Kains

Contributed equally to this work with: Stefan Bentink, Benjamin Haibe-Kains

Affiliations Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard School of Public Health, Boston, Massachusetts, United States of America

Thomas Risch

Affiliation Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

Jian-Bing Fan

Affiliation Illumina, Inc., San Diego, California, United States of America

Michelle S. Hirsch

Affiliations Department of Pathology, Division of Woman's and Perinatal Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Kristina Holton

Affiliation Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

Renee Rubio

Affiliation Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

Craig April

Affiliation Illumina, Inc., San Diego, California, United States of America

Jing Chen

Affiliation Illumina, Inc., San Diego, California, United States of America

Eliza Wickham-Garcia

Affiliation Illumina, Inc., San Diego, California, United States of America

Joyce Liu

Affiliations Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Aedin Culhane

Affiliations Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard School of Public Health, Boston, Massachusetts, United States of America

Ronny Drapkin

Affiliations Department of Pathology, Division of Woman's and Perinatal Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

John Quackenbush

johnq@jimmy.harvard.edu

These authors also contributed equally to this work.

Affiliations Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard School of Public Health, Boston, Massachusetts, United States of America

Ursula A. Matulonis

These authors also contributed equally to this work.

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Competing Interests

The assays used in deriving the angiogenic signature from patients at the Dana-Farber Cancer Institute and Brigham and Women's Hospital were performed by scientists at Illumina, who market the DASL. Authors Jian-Bing Fan, Craig April, Jing Chen and Eliza Wickham-Garcia are employed by Illumina, Inc., a commercial company. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials and all data have been deposited in ArrayExpress.

Author Contributions

Conceived and designed the experiments: JQ UAM. Performed the experiments: KH RR J-BF CA JC EW-G. Analyzed the data: SB BH-K TR JQ. Contributed reagents/materials/analysis tools: MSH JL JB-F SB BH-K AC RD. Wrote the paper: BH-K SB UAM JQ.